Cannabidiol Market (2025-2032)
The Cannabidiol Market was valued at $9.32 billion in 2024. This market is expected to reach $71.06 billion by 2032 from an estimated $11.32 billion in 2025, at a CAGR of 30% during the forecast period from 2025 to 2032. Cannabidiol Market Size & Forecast The growth of this market is driven by the
- Published
- Nov 2024
- Pages
- 210
- Format
- PDF + Excel
- Report ID
- MRFB - 1041400
- Base year
- 2025
- 2024 · HISTORICAL
- $9.32B
- 2032
- $71.06B
- CAGR 2025–2032
- 30%
2024 baseline · 2025–2032 forecast at 30% CAGR · hover a bar for the value
Key highlights
By Product: In 2025, the CBD Oil Segment is Expected to Dominate the Cannabidiol Market
By Source: In 2025, the Hemp-sourced Cannabidiol Segment is Expected to Dominate the Cannabidiol Market
By Nature: In 2025, the Non-organic Segment is Expected to Dominate the Cannabidiol Market
By End User: In 2025, the Pharmaceuticals Segment is Expected to Account for the Largest Share of the Cannabidiol Market
By Distribution Channel: In 2025, the Business-to-Business (B2B) Segment is Expected to Account for a Larger Share of the Cannabidiol Market
By Geography: North America is Expected to Dominate the Cannabidiol Market in 2025
Report summary
| Particulars | Details |
|---|---|
| Number of Pages | 210 |
| Format | |
| Forecast Period | 2025–2032 |
| Base Year | 2025 |
| CAGR (Value) | 30% |
| Market Size (Value) in 2025 | USD 11.32 Billion |
| Market Size (Value)in 2032 | USD 71.06 Billion |
| Segments Covered | By Product · Cannabidiol Oil · Cannabidiol Isolates · Cannabidiol Concentrates · Others · By Source · Hemp-sourced Cannabidiol · Marijuana-sourced Cannabidiol · By Nature · Non-organic · Organic · By End User · Pharmaceuticals · Food & Beverages · Confectionary Products · Bakery Products · Beverages · Coffee & Tea Products · Other Food & Beverages · Personal Care Products · Skincare Products · Oils · Creams & Moisturizers · Masks & Serums · Other Skincare Products · Haircare Products · Deodorants & Perfumes · Other Personal Care Products · Nutraceuticals & Dietary Supplements · Other End Users · By Distribution Channel · Business to Business · Business to Consumer · Hospital Pharmacies · Others |
| Countries Covered | North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Netherlands, and Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Malaysia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, and Rest of Latin America), and the Middle East & Africa (South Africa, Saudi Arabia, UAE, and the Rest of Middle East & Africa). |
| Key Companies | Aurora Cannabis Inc. (Canada), Cannoid, LLC (U.S.), NuLeaf Naturals, LLC (U.S.), Medical Marijuana, Inc. (U.S.), PharmaHemp d.o.o. (Slovenia), Water for Living LLC (U.S.), Elixinol Global Limited (Australia), Isodiol International Inc. (U.S.), Tilray Brands, Inc. (Canada), Tweedle Farms (U.S.), Endoca LLC (U.S.), and CV Sciences, Inc. (U.S.). |
Report overview
Segments covered: product, source, nature, end user, distribution channel. Regions: North America, Europe, Asia-Pacific, Latin America.
The growth of this market is driven by the increasing legalization of cannabis, health benefits offered by cannabidiol-infused products, and increasing demand for cannabidiol in medical applications. Moreover, the growing adoption of cannabidiol in pet food and emerging economies in Asia-Pacific and Latin America are expected to create market growth opportunities for the stakeholders operating in this market. Furthermore, the introduction of cannabidiol-infused beverages is a major trend in the cannabidiol market.
Market dynamics
3 factors across 2 forcesIncreasing Legalization of Cannabis
The growing public awareness, changing legal landscape, and increasing acceptance of CBD product are boosting the demand for cannabis. More countries and states have started embracing cannabis for both recreational and medicinal use. As of 2025, 24 states, three territories, and the District of Columbia permitted cannabis use for recreational purpose and 37 states, three territories, and the District of Columbia permitted cannabis use for medicinal purposes. Notably, in February 2024, the German Bundestag approved the controlled use of cannabis, which allows adults to possess up to 50 grams of cannabis in private and up to 25 grams in public. In 2018, Canada legalized cannabis for both purposes.
As laws surrounding cannabis use soften, consumers are becoming more aware about the benefits of CBD, which has gained popularity for its potential therapeutic effects, such as reducing anxiety, alleviating pain, and improving sleep quality. This newfound accessibility is encouraging individuals who may have previously shied away from cannabis to explore its benefits, thus driving the demand for CBD products. From oils and tinctures to edibles and skincare, the variety available caters to a broad range of preferences and needs.
Moreover, the wellness trend is gaining momentum, with consumers actively seeking holistic and natural remedies. The perception of CBD as a safe and beneficial alternative to pharmaceuticals has led many to incorporate it into their daily health routines. As a result, wellness brands are increasingly integrating CBD into their offerings, creating a synergy that bolsters the compound's popularity.
Therefore, the ongoing legalization of cannabis is expected to support the growth of the CBD market significantly.
Health Benefits Offered by Cannabidiol-Infused Products
CBD, a non-psychoactive compound derived from the cannabis plant, is gaining traction for its potential therapeutic effects, which has spurred both consumer interest and market growth. The increasing awareness of health benefits associated with cannabidiol (CBD) has significantly driven the demand for CBD-infused products. CBD has numerous health benefits such as anxiety and stress reduction, pain management, neuroprotective properties, anti-inflammatory effects, and improved sleep quality, among others.
The primary health benefit of CBD is its ability to alleviate anxiety and stress. CBD helps in reduction in symptoms related to anxiety disorders, making CBD a popular alternative to traditional pharmaceuticals. Some studies suggest that CBD interacts with the body’s endocannabinoid system, potentially helping to regulate mood and promote a sense of calm. Pain relief is another major reason for the rising popularity of CBD products. CBD can be effective in managing chronic pain, inflammation, and even conditions like arthritis. As more individuals seek natural alternatives to over-the-counter pain medications, CBD offers a compelling option with fewer side effects.
Additionally, CBD is being explored for its neuroprotective properties, showing promise in managing conditions like epilepsy. The FDA has approved Epidiolex, a CBD-based medication for specific seizure disorders, which further bolsters confidence in CBD's therapeutic potential. Furthermore, CBD can improve sleep quality and duration after incorporating CBD into their nightly routines, addressing the growing prevalence of sleep disorders.
Furthermore, the rise of the wellness industry has fuelled demand for CBD-infused products in various forms, including oils, edibles, beverages, and topical applications. Consumers are increasingly seeking holistic approaches to health, and CBD fits well within this trend. The growing acceptance of cannabis-related products and with more extensive research, the demand for cannabidiol is expected to increase.
Table of contents
13 chapters · 138 sections · 210 pages · click to expandSegmental analysis
| Segment | Largest share (2025) | Fastest growth (2025–2032) |
|---|---|---|
| By Source | Hemp-sourced Cannabidiol | — |
By Source
- The hemp-sourced cannabidiol segment is expected to account for a larger share of the cannabidiol market.
- This segment’s large market share is primarily due to the widespread acceptance and legalization of hemp-derived products across various regions.
- In addition, hemp’s versatility allows it to be incorporated into a range of products, from food and beverages to pharmaceuticals.
- Furthermore, consumers increasingly prefer hemp-derived CBD for its lower THC content, due to its therapeutic benefits without psychoactive effects associated with marijuana.
- Furthermore, the hemp segment is also projected to register a higher CAGR during the forecast period.
- This growth is mainly driven by growing demand for hemp from personal care applications, including cosmetics and skincare.
- The growing consumer awareness and innovations in health and wellness are expected to further boost the growth of this market.
Geographic analysis
North America
Largest shareIn 2025, North America is expected to account for the largest share of the cannabidiol market, followed by Europe and Asia-Pacific. North America's significant market share can be attributed to several key factors, such as presence of key players, growing acceptance of CBD products, rising prevalence of chronic diseases, changing perceptions towards CBD consumption for both medical and recreational purposes, and ease of accessibility. Furthermore, in 2025, the U.S. is expected to account for a larger share in the North America cannabidiol market. Moreover, this region is expected to record the highest CAGR during the forecast period of 2025–2032, due to the increasing health and wellness trends, increasing awareness regarding the health benefits of cannabidiol, rising investments from leading players, and technological advancements in the production and processing of cannabidiol. North America Dominates the Cannabidiol Market
Competitive landscape
- January 2025
Aurora Cannabis Inc. (Canada) launched three new cannabis-infused beverages for the patients looking for alternative forms of cannabis to support their wellbeing. These are available in three flavors: neon rush, strawberry pineapple tropical fizz, and pineapple coconut fizz.
- July 2024
HealthyTOKYO K.K. (Japan) launched highly concentrated CBD oil (CBD Oil 18.2%) to support individuals for stress relief.
- April 2021
Canopy Growth Corporation (Canada) entered a partnership with Southern Glazer’s Wine & Spirits to leverage Quatreau – Canopy’s first line of CBD-infused beverages in the U.S. market.
- Aurora Cannabis Inc. · Canada
- Cannoid, LLC (U.S.)
- NuLeaf Naturals, LLC (U.S.)
- Medical Marijuana, Inc. (U.S.)
- PharmaHemp d.o.o · Slovenia
- Elixinol Global Limited · Australia
- Isodiol International Inc. (U.S.)
- Tilray Brands, Inc. · Canada
- Tweedle Farms (U.S.)
- Endoca LLC (U.S.)
- CV Sciences, Inc. (U.S.)
Frequently asked questions
The global cannabidiol market size was valued at $9.32 billion in 2024.
Cite this report
Meticulous Research. (2024). Cannabidiol Market - Global Opportunity Analysis And Industry Forecast (2025-2032) (Report No. MRFB - 1041400). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/cannabidiol-market-6083